Autopsy report · NCT05252923

Endothelial Protection in Convalescent COVID-19 Patients

“Lack of the eligible patients”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 month before it started.
• Ran for about 9 months before it stopped.
• 2 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

Pirogov Russian National Research Medical University

Sponsor type

University, hospital or other

Conditions

Endothelial Dysfunction; Inflammation; Thrombosis; COVID-19

Interventions

Sulodexide

Participants

2

Sites

1

Countries

Russia

Trials that died the same way

• Serial Evaluation of Drug-Eluting Stents Using OCT (STRUT-OCT)
  “Lack of eligible patients” (99% match in meaning)
• Efficacy of Botulinum Toxin Versus Lidocaine in Treating Masticatory Myofascial Face Pain Using Ultrasound and EMG Guided Techniques
  “Lack of eligible patients willing and able to participate” (92% match in meaning)
• Non-alcoholic Fatty Liver Disease (NAFLD) in HIV: The Role of Nutritional Interventions
  “Not enough eligible patients available” (91% match in meaning)
• TRAUMA HELP: Healing and Analgesia With Propranolol
  “Lack of eligible patient recruits/feasibility considerations.” (86% match in meaning)
• REEDUCATION OF OLFACTORY DISORDERS AFTER A CEREBRAL VASCULAR ACCIDENT IN ADULTS
  “lack of patients” (85% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.